Roche and Ascidian agree to $1.8bn neurological disease partnership

Researchers identify new major cause of inflammatory bowel disease

UCB’s Bimzelx approved by MHRA for hidradenitis suppurativa

The evolutionary lessons for Bayer’s management restructure

Collecting the right data in the right way for the right reasons

How much time do you spend thinking about the impact of what is working and what is not in today’s organisational reality, versus what was captured in the situational analysis in your brand plan?

Researchers identify new major cause of inflammatory bowel disease

Roche and Ascidian agree to $1.8bn neurological disease partnership

UCB’s Bimzelx approved by MHRA for hidradenitis suppurativa

The evolutionary lessons for Bayer’s management restructure

Collecting the right data in the right way for the right reasons

How much time do you spend thinking about the impact of what is working and what is not in today’s organisational reality, versus what was captured in the situational analysis in your brand plan?